HOME >> BIOLOGY >> NEWS
Nanotechnology: consumers must be convinced benefits outweigh risks

Washington -- There is no doubt that nanotechnology has the potential to make the world a better place, said Project on Emerging Nanotechnologies Chief Scientist Andrew Maynard. But if consumers and other stakeholders are not convinced that the benefits outweigh the risks, many applications will not see the light of day. Likewise, if the benefits are unclear and the risks uncertain, the products of nanotechnology will be a hard sell.

Dr. Maynards remark is in his presentation today before a public meeting of the Presidents Council of Advisors on Science and Technology (PCAST). He spoke as part of a panel devoted to addressing and managing the potential health, environmental and safety risks of nanotechnology.

Nanotechnology is turning our world upside down...It also is shaking up our understanding of what makes something harmful and how we deal with that, according to Maynard. He described the current U.S. policy toward managing the possible health and safety risks of nanotechnologies as approaching 21st century technologies with a 20th century mindset.

Maynard called on the federal government to develop a goal-driven risk research strategy to provide decision-makersincluding regulators, industry and consumerswith the scientific information they need to help develop and use nanotechnologies as safely as possible. He suggested an international approach to this challenge based on a set of strategic research questions developed by thirteen top scientists last year which were published in the journal Nature.

The paper, Safe handling of nanotechnology (Maynard et al., Nature, vol. 44, 16 November 2006), was praised as a landmark in the history of nanotechnology research by the then chair Sherwood Boehlert (R-NY) and ranking member Bart Gordon (D-TN) of the U.S. Congresss House Science Committee. In a statement about the papers findings, the Congressmen said they both had made it clear that they felt the Administration was mov
'"/>

Contact: Alex Parlini
alex.parlini@wilsoncenter.org
202-691-4282
Project on Emerging Nanotechnologies
25-Jun-2007


Page: 1 2

Related biology news :

1. Green Nanotechnology: Its Easier Than You Think
2. Nanotechnology: The story behind the headlines
3. Leanest teens are biggest energy users and consumers
4. Research on salmonella in the poultry industry may result in safer food for consumers
5. Dietary Guidelines Alliance offers tools to help consumers understand new nutrition guidance
6. Researchers convinced satellites are helpful in tracking epidemics
7. Cardio exercise benefits in male vs. female hearts
8. Researchers probe risks, benefits of folic acid fortification
9. Research ends debate over benefits of butterfly defenses
10. Penn study finds ICD devices offer heart patients life-saving benefits
11. Wilson Center and Pew Charitable Trusts expand efforts to examine risks/benefits of nanotechnology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/4/2019)... ... January 03, 2019 , ... Over the ... into their drug discovery research workflows with biology ranging from single cell-type spheroids ... of in vitro studies, they create several challenges that need to be overcome ...
(Date:12/27/2018)... FRANCISCO (PRWEB) , ... December 27, 2018 , ... ... annual Microbiome Conference at JPM as part of the JP Morgan 37th Annual ... innovative scientists and physicians, and members of the investment community. , Since ...
(Date:12/20/2018)... ... December 20, 2018 , ... Human Factors and product ... a new usability/observation room. This addition will help meet the increased industry demand ... delivery devices/combination products are safe and easy to use when released to the ...
Breaking Biology News(10 mins):
(Date:1/10/2019)... Fla. (PRWEB) , ... January ... ... Geometrical Implant Co, (SAGICO), an innovative spinal implant company, announced today that ... in San Francisco, California. The annual J.P. Morgan Healthcare Conference is ...
(Date:1/7/2019)... SEONGNAM, South Korea (PRWEB) , ... January 07, ... ... has completed Phase 1 clinical trials of its Parkinson's Disease drug candidate, code-named ... disease-modifying treatment of Parkinson's Disease. The trial took place in South Korea. ...
(Date:1/4/2019)... ... January 03, 2019 , ... Calidi Biotherapeutics, Inc., ... today announced the founding of a scientific and medical advisory board (SMAB). The ... leaders in the Immuno-Oncology field. The founding members of Calidi Biotherapeutics SMAB include ...
(Date:12/18/2018)... ... December 17, 2018 , ... ABCT ... emerging biosciences ventures invited to participate in the annual program. Twelve ventures will ... plans and a professional network. All startups receive an entrepreneur coach, access to ...
Breaking Biology Technology:
Cached News: